Related references
Note: Only part of the references are listed.Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
Rima Kamel et al.
NATURE REVIEWS CARDIOLOGY (2023)
Compartmentalized cAMP signaling in cardiac ventricular myocytes
Shailesh R. Agarwal et al.
CELLULAR SIGNALLING (2022)
Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage
Maria Ercu et al.
CIRCULATION (2022)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Bin Zhou et al.
LANCET (2021)
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
Faisa Omar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease
Arantxa Gonzalez et al.
HYPERTENSION (2018)
Functions of PDE3 Isoforms in Cardiac Muscle
Matthew Movsesian et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2018)
Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction
Christiane Vettel et al.
CIRCULATION RESEARCH (2017)
RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5
Graeme B. Bolger
CELLULAR SIGNALLING (2016)
Regulation of Sarcoplasmic Reticulum Ca2+ ATPase 2 (SERCA2) Activity by Phosphodiesterase 3A (PDE3A) in Human Myocardium PHOSPHORYLATION-DEPENDENT INTERACTION OF PDE3A1 WITH SERCA2
Faiyaz Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
PDE3A mutations cause autosomal dominant hypertension with brachydactyly
Philipp G. Maass et al.
NATURE GENETICS (2015)
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Miles D. Houslay
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Calcium cycling and signaling in cardiac myocytes
Donald M. Bers
ANNUAL REVIEW OF PHYSIOLOGY (2008)